PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.117, Iss.1, 2014-03, pp. : 7-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Potential role of PI3K inhibitors in the treatment of breast cancer

By Carvalho Sílvia Schmitt Fernando

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1251-1263

Future Medicine

Access to resources Recommend Favorite

Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 29-57

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts

By Bartolotti Marco Franceschi Enrico Brandes Alba A

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1653-1664

Future Medicine

Access to resources Recommend Favorite

HER2-positive Breast Cancer Brain Metastases: Multiple Responses to Systemic Chemotherapy and Trastuzumab—a Case Report

By Church D. Bahl A. Jones A. Price C.

Journal of Neuro-Oncology, Vol. 79, Iss. 3, 2006-09 ,pp. : 289-292

Springer Publishing Company

Access to resources Recommend Favorite

Occult brain metastases in HER2-positive breast cancer patients: Frequency and response to radiotherapy

By Niwinska Anna Tacikowska Małgorzata Pienkowski Tadeusz

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 1027-1029

Informa Healthcare

Access to resources Recommend Favorite